Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Muir Roshell, Metcalf Talibah, Fourati Slim, Bartsch Yannic, Lugemwa Jacqueline Kyosiimire, Canderan Glenda, Alter Galit, Muyanja Enoch, Okech Brenda, Namatovu Teddy, Namara Irene, Namuniina Annemarie, Ssetaala Ali, Mpendo Juliet, Nanvubya Annet, Kitandwe Paul Kato, Bagaya Bernard S, Kiwanuka Noah, Nassuna Jacent, Biribawa Victoria Menya, Elliott Alison M, de Dood Claudia J, Senyonga William, Balungi Priscilla, Kaleebu Pontiano, Mayanja Yunia, Odongo Mathew, Fast Pat, Price Matt A, Corstjens Paul L A M, van Dam Govert J, Kamali Anatoli, Sekaly Rafick Pierre, Haddad Elias K
Аннотация
AUTHOR SUMMARY: Schistosomiasis drives host immune responses for optimal pathogen survival, potentially altering host responses to vaccine-related antigen. Chronic schistosomiasis and co-infection with hepatotropic viruses are common in countries where schistosomiasis is endemic. We explored the impact of Schistosoma mansoni ( S. mansoni ) infection on Hepatitis B (HepB) vaccination of individuals from a fishing community in Uganda. We demonstrate that high schistosome-specific antigen (circulating anodic antigen, CAA) concentration pre-vaccination, is associated with lower HepB antibody titers post-vaccination. We show higher pre-vaccination levels of cellular and soluble factors in instances of high CAA that are negatively associated with HepB antibody titers post-vaccination, which coincided with lower frequencies of circulating T follicular helper cell populations (cTfh), proliferating antibody secreting cells (ASCs), and higher frequencies of regulatory T cells (Tregs). We also show that monocyte function is important in HepB vaccine responses, and that high CAA is associated with alterations in the early innate cytokine/chemokine microenvironment. Our findings suggest that in individuals with high CAA and likely high worm burden, schistosomiasis creates and sustains an environment that is polarized against optimal host immune responses to the vaccine, which puts many endemic communities at risk for infection against HepB and other diseases that are preventable by vaccines.